NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Satoshi Tanaka
National Hospital Organization - Tokyo / Japan
Others
AD Scientific Index ID: 4927815
国立病院機構
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Satoshi Tanaka's MOST POPULAR ARTICLES
1-)
Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in miceS Tanaka, H Hikita, T Tatsumi, R Sakamori, Y Nozaki, S Sakane, Y Shiode, ...Hepatology 64 (6), 1994-2014, 20162352016
2-)
Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinomaH Murai, T Kodama, K Maesaka, S Tange, D Motooka, Y Suzuki, ...Hepatology 77 (1), 77-91, 2023612023
3-)
Bak deficiency inhibits liver carcinogenesis: a causal link between apoptosis and carcinogenesisH Hikita, T Kodama, S Shimizu, W Li, M Shigekawa, S Tanaka, A Hosui, ...Journal of hepatology 57 (1), 92-100, 2012602012
4-)
Interleukin-6 is a circulating prognostic biomarker for hepatocellular carcinoma patients treated with combined immunotherapyY Myojin, T Kodama, R Sakamori, K Maesaka, T Matsumae, Y Sawai, ...Cancers 14 (4), 883, 2022602022
5-)
ST6GAL1 is a novel serum biomarker for lenvatinib-susceptible FGF19-driven hepatocellular carcinomaY Myojin, T Kodama, K Maesaka, D Motooka, Y Sato, S Tanaka, Y Abe, ...Clinical Cancer Research 27 (4), 1150-1161, 2021562021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept